Community pharmacy is at the heart of the 10-Year Plan for the NHS, with this year’s investment into the CPCF a clear signal of Government’s commitment to the sector, Minister of State for Care Stephen Kinnock MP has told LPCs. Addressing the Forum of LPC Chairs in Westminster on Monday, Minister Kinnock described community pharmacy [...]
The post Minister confirms commitment to pharmacy appeared first on Community Pharmacy England.
MHRA Class 3 Medicines Recall: Cyclizine Lactate 50 mg/ml Solution for injection (Orbit Pharma Limited) Drug Alert Number: EL(26)A/29 Date issued: 16 June 2026 Orbit Pharma Limited is recalling a specific batch of Cyclizine Lactate 50 mg/ml Solution for injection as a precautionary measure due to Good Manufacturing Practice (GMP) deficiencies identified at the manufacturing site. [...]
The post MHRA Class 3 Medicines Recall: Cyclizine Lactate 50 mg/ml Solution for injection (Orbit Pharma Limited) appeared first on Community Pharmacy England.
The General Pharmaceutical Council (GPhC) has published advice for newly qualified prescribing pharmacists, ahead of the first cohort joining the register as independent prescribers from summer 2026. The advice is aimed at pharmacists who have completed their MPharm under the 2021 initial education and training standards and will join the register as pharmacist independent prescribers. [...]
The post Advice published for newly qualified prescribing pharmacists appeared first on Community Pharmacy England.
The Department of Health and Social Care (DHSC) and NHS England have announced a new community pharmacy vaccination service to provide a one-off Meningococcal B (MenB) Vaccination Service. The new Advanced service is targeted to protect young people heading to universities or residential further education ahead of the start of term in autumn 2026. Negotiations [...]
The post Pharmacies to provide new MenB vac service appeared first on Community Pharmacy England.
The Department of Health and Social Care (DHSC) has issued a medicine supply notification for the following products: Aztreonam 1g powder for solution for injection vials Aztreonam 1g powder for solution for injection vials MSN/2025/025 Tier 2 – medium impact Date of issue: 11/06/2026 Summary Aztreonam 2g powder for solution for injection vials are currently [...]
The post Medicine Supply Notification: Aztreonam 1g and 2g powder for solution for injection vials appeared first on Community Pharmacy England.
Recent Comments